EncaminC

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEncaminC
Drug Alias Namefibroblast growth factor receptor antagonists (Enkam Pharmaceuticals)FGFR antagonists (Enkam Pharmaceuticals)ENK-835ENK-834
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptors antagonistsAnticancer protein kinase inhibitors
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnkam Pharmaceuticals A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnkam Pharmaceuticals A/S
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A